EA201791467A1 - Водный офтальмологический раствор - Google Patents

Водный офтальмологический раствор

Info

Publication number
EA201791467A1
EA201791467A1 EA201791467A EA201791467A EA201791467A1 EA 201791467 A1 EA201791467 A1 EA 201791467A1 EA 201791467 A EA201791467 A EA 201791467A EA 201791467 A EA201791467 A EA 201791467A EA 201791467 A1 EA201791467 A1 EA 201791467A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ophthalmic solution
aqueous ophthalmic
concentration
aqueous
diquafozole
Prior art date
Application number
EA201791467A
Other languages
English (en)
Other versions
EA034517B1 (ru
Inventor
Кодзи Инагаки
Наоки Мацумото
Тосихиро Огава
Йукихиса Вакабаяси
Асука Камимура
Йосихиро Осита
Хитоси Накадзава
Исао Мацуока
Original Assignee
Сантен Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56150716&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201791467(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Сантен Фармасьютикал Ко., Лтд. filed Critical Сантен Фармасьютикал Ко., Лтд.
Publication of EA201791467A1 publication Critical patent/EA201791467A1/ru
Publication of EA034517B1 publication Critical patent/EA034517B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C13/00—Assembling; Repairing; Cleaning

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Настоящее изобретение относится к водному офтальмологическому раствору, содержащему диквафозол или его соль в концентрации от 0,1 до 10% (мас./об.) и хлоргексидин в концентрации от 0,0001 до 0,1% (мас./об.).
EA201791467A 2014-12-25 2015-12-25 Водный офтальмологический раствор EA034517B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014263003 2014-12-25
JP2015114595 2015-06-05
PCT/JP2015/086230 WO2016104704A1 (ja) 2014-12-25 2015-12-25 水性点眼液

Publications (2)

Publication Number Publication Date
EA201791467A1 true EA201791467A1 (ru) 2017-11-30
EA034517B1 EA034517B1 (ru) 2020-02-17

Family

ID=56150716

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791467A EA034517B1 (ru) 2014-12-25 2015-12-25 Водный офтальмологический раствор

Country Status (13)

Country Link
US (2) US10278985B2 (ru)
JP (3) JP6779614B2 (ru)
KR (3) KR101867791B1 (ru)
AR (1) AR105199A1 (ru)
BR (1) BR112017013841A2 (ru)
CA (1) CA2971689C (ru)
EA (1) EA034517B1 (ru)
MX (1) MX2017008277A (ru)
MY (1) MY182507A (ru)
PH (1) PH12017501096A1 (ru)
SG (1) SG11201705138QA (ru)
TW (1) TWI709405B (ru)
WO (1) WO2016104704A1 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6104433B2 (ja) * 2015-06-05 2017-03-29 参天製薬株式会社 水性点眼液
SG11201705138QA (en) * 2014-12-25 2017-07-28 Santen Pharmaceutical Co Ltd Aqueous ophthalmic solution
RU2742032C2 (ru) * 2015-06-05 2021-02-01 Сантен Фармасьютикал Ко., Лтд. Терапевтическое средство против сухости глаз, характеризуемое нанесением на глаза пациентов с сухостью глаз, носящих гибкие контактные линзы
KR20220163519A (ko) * 2018-02-28 2022-12-09 산텐 세이야꾸 가부시키가이샤 디쿠아포솔 및 양이온성 폴리머를 함유하는 안과용 조성물
KR20240049646A (ko) * 2019-08-27 2024-04-16 산텐 세이야꾸 가부시키가이샤 디쿠아포솔 또는 그 염 및 폴리비닐피롤리돈을 함유하는 수성 안과용 조성물
US11229549B2 (en) * 2019-09-18 2022-01-25 Vance M. Thompson Tear transplantation and multi-part contact lens with absorbent portion
JP2023531596A (ja) 2020-06-23 2023-07-25 テジュン ファーマシューティカル カンパニー リミテッド ジクアホソルを含む点眼組成物
KR102365008B1 (ko) 2020-06-23 2022-02-23 주식회사태준제약 디쿠아포솔을 포함하는 점안 조성물
KR102548710B1 (ko) 2020-12-24 2023-06-28 주식회사 종근당 디쿠아포솔 또는 이의 약제학적으로 허용가능한 염과 토코페롤을 함유하는 건성안 예방 또는 치료용 약제학적 조성물
JP7230169B2 (ja) * 2020-12-25 2023-02-28 参天製薬株式会社 ジクアホソルまたはその塩、銀塩およびイオン性等張化剤を含有する水性点眼液
WO2024010040A1 (ja) * 2022-07-06 2024-01-11 ロート製薬株式会社 眼科組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09301858A (ja) 1996-05-13 1997-11-25 Senju Pharmaceut Co Ltd グルコン酸クロルヘキシジン安定化水性薬剤
JPH10203960A (ja) * 1997-01-24 1998-08-04 Ofutekusu:Kk 点眼液組成物
JPH1160505A (ja) 1997-05-20 1999-03-02 Senju Pharmaceut Co Ltd 防腐組成物
JP2008222638A (ja) 2007-03-13 2008-09-25 Teika Seiyaku Kk 油成分含有眼用組成物
JP2009073788A (ja) 2007-09-21 2009-04-09 Teika Seiyaku Kk イソプロピルウノプロストン含有眼用組成物
JP5398452B2 (ja) 2008-09-30 2014-01-29 大正製薬株式会社 点眼剤
WO2011016562A1 (ja) 2009-08-07 2011-02-10 ロート製薬株式会社 シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP6047272B2 (ja) * 2010-09-15 2016-12-21 テイカ製薬株式会社 角膜上皮障害治療用点眼剤
SG10201508591UA (en) * 2010-12-28 2015-11-27 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate
MX353874B (es) * 2012-03-26 2018-02-01 Santen Pharmaceutical Co Ltd Gotas para los ojos que contienen diquafosol.
SG11201705138QA (en) 2014-12-25 2017-07-28 Santen Pharmaceutical Co Ltd Aqueous ophthalmic solution

Also Published As

Publication number Publication date
US20170348344A1 (en) 2017-12-07
BR112017013841A2 (pt) 2018-06-19
MY182507A (en) 2021-01-25
WO2016104704A1 (ja) 2016-06-30
JP2016210759A (ja) 2016-12-15
US10786526B2 (en) 2020-09-29
JP2022166223A (ja) 2022-11-01
JP2021008513A (ja) 2021-01-28
KR20180063381A (ko) 2018-06-11
KR102330736B1 (ko) 2021-11-23
KR20170118255A (ko) 2017-10-24
SG11201705138QA (en) 2017-07-28
US10278985B2 (en) 2019-05-07
CA2971689C (en) 2020-11-03
PH12017501096A1 (en) 2017-11-27
AR105199A1 (es) 2017-09-13
MX2017008277A (es) 2017-10-02
CA2971689A1 (en) 2016-06-30
JP6779614B2 (ja) 2020-11-04
TW201628626A (zh) 2016-08-16
US20190209599A1 (en) 2019-07-11
JP7128243B2 (ja) 2022-08-30
KR101867791B1 (ko) 2018-06-15
KR101789019B1 (ko) 2017-10-20
EA034517B1 (ru) 2020-02-17
KR20170067900A (ko) 2017-06-16
TWI709405B (zh) 2020-11-11

Similar Documents

Publication Publication Date Title
EA201791467A1 (ru) Водный офтальмологический раствор
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201792354A1 (ru) Композиции обетихолевой кислоты и способы применения
EA201890204A1 (ru) Антибактериальные соединения
EA201790649A1 (ru) Бензилзамещенные индазолы в качестве ингибиторов bub 1
EA201791775A1 (ru) Цистеиновая протеаза
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
EA201790434A1 (ru) Модуляторы каналов
EA201790266A1 (ru) Индолы для применения при инфекции, вызванной вирусом гриппа
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
AR096478A1 (es) Composiciones para el tratamiento de superficie que comprenden tintes fotocromáticos
EA201790380A1 (ru) Ингибиторы mk2 и их применения
EA201790655A1 (ru) Новые активаторы растворимой гуанилатциклазы и их применение
EA201791174A1 (ru) Антимикотическое соединение
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA201692284A1 (ru) Ниацинамид для стимуляции продуцирования антимикробных пептидов
EA201792000A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA201792262A1 (ru) Пироглутамат вортиоксетина
EA201891783A1 (ru) Композиция для растворения аморфных дитиазинов и способ ее применения
MA44601A (fr) Composition ophtalmique contenant de la pvp-i
EA201790809A1 (ru) Композиция для укладки волос
EA201992168A1 (ru) Аналоги деутетрабеназина, их получение и применение
EA201790851A1 (ru) Способы предотвращения, уменьшения и лечения макулодистрофии
TR201819920T4 (tr) Kuru göz sendromunun tedavisinde kullanım için oftalmik bileşimler.
EA201501130A1 (ru) Офтальмологическая фармацевтическая композиция

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM